Angiodynamics Inc. (ANGO) intrinsic value & 10-year financials
Angiodynamics Inc. (ANGO) has a Graham intrinsic value of $6.11 per share. At $11.24 on Oct 17, 2026, the stock trades 84% above that value. Over the last 10 fiscal years revenue shrank 2.1% a year to $292.5M, with an average return on invested capital of -16.1%.
- Graham intrinsic value
- $6.11
- Share price (Oct 17, 2026)
- $11.24
- Price vs Graham value
- 84% above
- Market cap
- $459.2M
- Revenue (FY2025)
- $292.5M
- Revenue growth (10-yr CAGR)
- -2.1%
- ROIC (10-yr avg)
- -16.1%
- Free cash flow (FY2025)
- -$14.6M
ANGO 10-year financial history
| Fiscal year | Revenue | Net income | EPS (diluted) | Free cash flow | Operating margin | ROIC |
|---|---|---|---|---|---|---|
| FY2025 | $292.5M | -$34.0M | -$0.83 | -$14.6M | -13.7% | -29.7% |
| FY2024 | $303.9M | -$184.3M | -$4.59 | -$30.7M | -63.3% | -71.2% |
| FY2023 | $338.8M | -$52.4M | -$1.33 | -$3.7M | -15.1% | -12.1% |
| FY2022 | $316.2M | -$26.5M | -$0.68 | -$11.5M | -9.0% | -6.1% |
| FY2021 | $291.0M | -$31.5M | -$0.82 | $18.9M | -12.1% | -7.6% |
| FY2020 | $264.2M | -$166.8M | -$4.39 | -$21.8M | -63.3% | -35.7% |
| FY2019 | $270.6M | $61.3M | $1.64 | $34.3M | -3.5% | -1.7% |
| FY2018 | $344.3M | $16.3M | $0.44 | $38.9M | 3.1% | 1.9% |
| FY2017 | $349.6M | $5.0M | $0.14 | $52.7M | 3.7% | 1.3% |
| FY2016 | $353.9M | -$43.6M | -$1.21 | $42.9M | 0.3% | 0.2% |
Source: annual 10-K filings on SEC EDGAR. Figures in USD.
Executive summary
ANGIODYNAMICS INC is facing top-line stagnation, with revenue contracting over the decade.
ANGIODYNAMICS INC has historically struggled to out-earn its cost of capital, averaging just -16.1% ROIC.
ANGIODYNAMICS INC has not shown aggressive share repurchases (>10% retirement) or a major balance-sheet leverage increase (>50% net debt growth) over the 10-year window.
Benjamin Graham lens
Under Benjamin Graham's formula using SEC EDGAR fundamentals, ANGIODYNAMICS INC is modeled at -2.1% normalized earnings growth with a 5.1% bond-yield adjustment. The resulting Graham intrinsic value estimate is $6.11 per share.